Collaborate Disseminate
A peptide called MOTS-c has shown promise in preventing type 1 diabetes, according to new tests in human cells in culture and live mice. The peptide seems to regulate the immune system, potentially leading to treatments for type 1 diabetes and other au… Continue reading Type 1 diabetes prevented in mice by immune-cell-regulating peptide
An artificial pancreas has been trialed in patients with type 2 diabetes for the first time. The device monitors a person’s blood glucose levels and automatically administers insulin when needed – and the results so far are promising.Continue ReadingCa… Continue reading Artificial pancreas trialed in patients with type 2 diabetes
For sufferers of diabetes, keeping blood glucose levels within a healthy range can be a difficult and labor-intensive balancing act that often requires regular insulin injections, but some scientists imagine a future where medicine does the heavy lifti… Continue reading “Synthetic hinge” opens a door to smart, glucose-responsive insulin
New research has found a maternal fecal transplant may mitigate the damage antibiotics cause to the development of a newborn baby’s microbiome. The animal study focused specifically on a mouse model of type 1 diabetes, finding a fecal transplant greatl… Continue reading Restoring a baby’s gut bacteria could reduce future diabetes risk
Diabetes has a long list of run-on health effects, and one of them is an increased risk of cardiovascular disease. Now, scientists at Oxford have uncovered a mechanism behind that, finding high blood sugar levels “reprogram” stem cells so the white blo… Continue reading Stem cells “reprogrammed” by diabetes could increase heart attack risk
Diabetes has a long list of run-on health effects, and one of them is an increased risk of cardiovascular disease. Now, scientists at Oxford have uncovered a mechanism behind that, finding high blood sugar levels “reprogram” stem cells so the white blo… Continue reading Stem cells “reprogrammed” by diabetes could increase heart attack risk
Accumulation of fat specifically around the heart has long been linked to cardiovascular and metabolic disease but until now there hasn’t been a simple way to measure this. A new artificial intelligence tool has been developed that can quantify these f… Continue reading AI tool can measure fat around the heart and calculate one’s diabetes risk
Researchers investigating new diabetes treatments believe they have found evidence indicating excess production of a key neurotransmitter in the liver could be a key causal factor in the onset of insulin resistance. The discovery points to novel preven… Continue reading New clues point to the liver playing a causal role in type 2 diabetes
By better understanding the biological underpinnings of different types of fat in the body, scientists hope to uncover new ways to tackle obesity and conditions relating to it. Researchers have now found that increasing levels of a certain protein in b… Continue reading Protein found to boost fat-burning, lower risk of diabetes
The US Food and Drug Administration (FDA) has approved a new weight management drug called Wegovy (semaglutide). The drug was first approved as a type 2 diabetes treatment in 2017 and has subsequently been described as a “game-changer” for obese or ove… Continue reading FDA approves “game-changing” new weight loss drug